Handelsavisen
prelaunch
HS
HSTI.PK OTC Drug Retailers

High Sierra Technologies Inc

$1,40
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
7,9 %
Net margin
Debt / equity
-1,12
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

High Sierra Technologies Inc operates in the drug retailing industry, providing pharmaceutical and consumer health products to customers.

Business. High Sierra Technologies Inc (HSTI.PK) operates in the Drug Retailers industry within the Consumer Non-Cyclicals sector. The company is headquartered in the United States and is listed on the OTC market. Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Drug Retailing
IndustryDrug Retailers
ActivityFood & Drug Retailing
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
7,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning HSTI.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to HSTI.PK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    High Sierra Technologies Inc (HSTI.PK) operates in the Drug Retailers industry within the Consumer Non-Cyclicals sector. The company is headquartered in the United States and is listed on the OTC market. Specific details regarding operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Drug Retailing
    IndustryDrug Retailers
    ActivityFood & Drug Retailing
    AI synthesis
    GENERATED

    High Sierra Technologies Inc has a negative equity position of -$436,270 million, indicating a significant financial distress with total liabilities of $584,670 million and total assets of $148,410 million. The company's liquidity is further strained by a current ratio of 0.12, suggesting a high risk of short-term insolvency. The negative operating cash flow of -$176,520 million and free cash flow of -$25,700 million indicate a lack of cash generation from operations.

    The company's profitability is severely negative, with a net income of -$34,540 million and an operating income of -$19,020 million. The return on equity of 7.92% is misleading due to the negative equity base, and the return on assets of -23.27% indicates a poor use of assets to generate profit. These metrics are far below the industry medians for profitability and returns, suggesting a significant underperformance relative to peers.

    The company's revenue is reported as $0 million, indicating a lack of disclosed revenue streams or operational activity. There is no information provided on geographic exposure or segment performance, making it difficult to assess revenue concentration or diversification.

    The company's growth trajectory is unclear due to the absence of revenue data and the negative financial performance. The outlook for the current and next fiscal years is not provided, but the negative operating and net income suggest a challenging environment for growth.

    The company faces significant liquidity and solvency risks, with a negative net cash position after subtracting total debt. The dilution risk is currently low, but the negative equity and high debt levels could lead to future dilution if the company requires additional capital. The adjustments applied in the valuation reflect the company's financial distress and the potential for further dilution.

    There are no recent events or filings provided that would indicate significant changes in the company's operations or financial status. The lack of disclosed revenue and the negative financial performance suggest a need for further investigation into the company's business model and financial health.

    Key takeaways
    • High Sierra Technologies Inc is in a severe financial distress with negative equity and high liabilities.
    • The company's profitability is extremely poor, with significant negative net and operating income.
    • There is no disclosed revenue, indicating a lack of operational activity or financial transparency.
    • The company's liquidity and solvency risks are high, with a negative net cash position and a low current ratio.
    • The outlook for growth is uncertain due to the absence of revenue data and negative financial performance.
    • The company's risk profile is dominated by liquidity and solvency concerns, with potential for future dilution.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    The company's cash conversion metric of 5.11 ranks above the 75th percentile within its peer group of 29 companies.

    Operating income improved by 6.9% year-over-year in the latest fiscal period, indicating a slight operational recovery trend.

    Net income losses narrowed by 2.4% year-over-year in the most recent fiscal year compared to the prior period.

    The debt-to-equity ratio is classified as best-in-class relative to the Drug Retailers cohort median of 0.38.

    BEAR CASE · 3

    The company carries a high credit risk flag, reflecting significant concerns regarding its ability to meet financial obligations.

    High Sierra Technologies reported zero revenue across all five analyzed fiscal periods, indicating a lack of core business income.

    A current ratio of 0.0889 indicates severe liquidity constraints, as current assets cover less than 9% of current liabilities.

    In focus — financials by report

    Valuation FY

    Market price
    $1,40
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    -$436.3k
    Net cash
    -$488.8k
    Current ratio
    0.1
    Debt / equity
    -1.1
    ROA
    -23.3%
    ROE
    7.9%
    Cash conversion
    511.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE7,9 %Above median
    D/E-1,12Best in class
    Cash Conv5,11Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • High Sierra Technologies Inc Market data — financials · 2026-05-28

    Ownership & reference

    Leadership

    • Vincent LombardiPresident, Chief Executive Officer, Director

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    HSTI.PKCanonical
    OTC · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Total liabilities (YoY) (2022-12-31 vs 2021-12-31): 4.6%Derived (calculated)
    • Shareholders' equity (YoY) (2022-12-31 vs 2021-12-31): -17.0%Derived (calculated)
    • Total assets (YoY) (2022-12-31 vs 2021-12-31): -31.6%Derived (calculated)
    • EPS (diluted) (YoY) (2022-12-31 vs 2021-12-31): 50.0%Derived (calculated)
    • EPS (basic) (YoY) (2022-12-31 vs 2021-12-31): 50.0%Derived (calculated)
    • Return on equity (FY 2022-12-31): 63.5%Derived (calculated)
    • Return on assets (FY 2022-12-31): -319.2%Derived (calculated)
    • Current ratio (FY 2022-12-31): 0.04xDerived (calculated)
    • Debt-to-equity (FY 2022-12-31): -1.20xDerived (calculated)
    • Net income (YoY) (2022-12-31 vs 2021-12-31): -2.4%Derived (calculated)
    • Operating cash flow (YoY) (2022-12-31 vs 2021-12-31): -24.4%Derived (calculated)
    • Operating income (YoY) (2022-12-31 vs 2021-12-31): 6.9%Derived (calculated)
    • Operating cash flow (annual): USD -219.66KSEC XBRL filing
    • Total liabilities (annual): USD 611.78KSEC XBRL filing
    • Pre-tax income (annual): USD -323.95KSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Total assets (annual): USD 101.5KSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Shares outstanding (annual): 20.62MSEC XBRL filing
    • Interest expense (annual): USD 66.47KSEC XBRL filing
    • Capex (annual): USD 43.44KSEC XBRL filing
    • Current liabilities (annual): USD 561.78KSEC XBRL filing
    • Shareholders' equity (annual): USD -510.28KSEC XBRL filing
    • Net income (annual): USD -323.95KSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage